CNBC TV 18 - India
Dr Reddy’s Nerivio, a USFDA-approved migraine relief device, offers a convenient, pulse-based treatment through ‘remote electrical neuromodulation (REN).’ Despite occasional efficacy variations, it proves beneficial, especially for severe attacks. Priced at ₹16,000, it requires a prescription and offers an alternative to traditional migraine medications.
Read More
Fierce Biotech
Theranica’s Nerivio, a prescription wearable device used to mitigate migraines, went from being a reactive approach of treating symptoms to a proactive tool for helping prevent them. Earlier this year and just a few months after submitting a new 510(k) to expand indications for the technology, the FDA cleared the device for people who experience […]
Read More
Fast Company
For treating adolescent migraines. Migraines are debilitating, but most treatment options focus on adults. Theranica‘s Nerivio wearable is targeting the 100 million adolescents worldwide who are impacted by migraines. The company’s FDA-approved treatment uses a smartphone app and a product that wraps around a user’s upper arm to trigger a natural process in the brain to […]
Read More
Local 10 News
Recent research is showing that a non-systemic treatment can provide relief from migraine headaches, which affect an estimated 12% of Americans. Dr. Teshamae Monteith is an associate professor of clinical neurology and chief of the headache division at the University of Miami Health System. Monteith said a study involving adolescents found that an app-controlled neuromodulation […]
More
Fox News
A teenager and her mom are driving more than 300 miles from Arkansas to Kansas City for what they call a miracle treatment. With migraines so bad that 17-year-old Sonja Burnett said she could barely walk anymore, every single mile of the trek will be worth it. After nearly 4 years of not leaving her […]
More
Practical Pain management
The FDA has approved Nerivio as a preventive treatment for migraine, with or without aura, in adults and children 12 years old and older. The non-invasive prescription wearable had already been approved as a treatment for acute migraine in adolescents and adults. The device’s dual-use approval opens up new options for migraine care in adolescents and adults.
More
Fierce Biotech
With almost two more years having passed since the company successfully lobbied the FDA to expand its Nerivio neuromodulation armband indication as an acute migraine treatment from adults only to all patients aged 12 and older with episodic or chronic migraine, Theranica is once again asking the agency to expand the device’s approved usage. Its […]
More
Health Tech World
Theranica says it has demonstrated clinical evidence equivalent to commonly prescribed medications and serves more than 25,000 people with migraine, including adolescents and adults, in the USA. Health Tech World speaks with Alon Ironi, CEO of Theranica, to learn more about the wearable that’s got big pharmaceutical companies worried.
More
Channel 3 Eyewitness News
Connecticut’s Channel 3 Eyewitness News segment focus on the Nerivio device for easing migraine pain. Dr. Brian Grosberg, medical director of the HHC headache program at Hartford healthcare CT, explains the mechanism and benefits of Nerivio.
More
MedCity News
Several medical devices using electrical neuromodulation have been developed to treat pain, spinal injuries, epilepsy, migraine, and other conditions. More than just a new technological solution, the possibility presented by these devices is significant.
More